APA
Paré G., Ross S., Mehta S. R., Yusuf S., Anand S. S., Connolly S. J., Fox K. A. A. & Eikelboom J. W. (20120827). Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events. : Circulation. Cardiovascular genetics.
Chicago
Paré Guillaume, Ross Stephanie, Mehta Shamir R, Yusuf Salim, Anand Sonia S, Connolly Stuart J, Fox Keith A A and Eikelboom John W. 20120827. Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events. : Circulation. Cardiovascular genetics.
Harvard
Paré G., Ross S., Mehta S. R., Yusuf S., Anand S. S., Connolly S. J., Fox K. A. A. and Eikelboom J. W. (20120827). Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events. : Circulation. Cardiovascular genetics.
MLA
Paré Guillaume, Ross Stephanie, Mehta Shamir R, Yusuf Salim, Anand Sonia S, Connolly Stuart J, Fox Keith A A and Eikelboom John W. Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events. : Circulation. Cardiovascular genetics. 20120827.